APA

McCall R. B., Romero A. G., Bienkowski M. J., Harris D. W., McGuire J. C., Piercey M. F., Shuck M. E., Smith M. W., Svensson K. A. & Schreur P. J. (19941229). Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist. : The Journal of pharmacology and experimental therapeutics.

Chicago

McCall R B, Romero A G, Bienkowski M J, Harris D W, McGuire J C, Piercey M F, Shuck M E, Smith M W, Svensson K A and Schreur P J. 19941229. Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist. : The Journal of pharmacology and experimental therapeutics.

Harvard

McCall R. B., Romero A. G., Bienkowski M. J., Harris D. W., McGuire J. C., Piercey M. F., Shuck M. E., Smith M. W., Svensson K. A. and Schreur P. J. (19941229). Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist. : The Journal of pharmacology and experimental therapeutics.

MLA

McCall R B, Romero A G, Bienkowski M J, Harris D W, McGuire J C, Piercey M F, Shuck M E, Smith M W, Svensson K A and Schreur P J. Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist. : The Journal of pharmacology and experimental therapeutics. 19941229.